ATE223204T1 - Liposomenzusammensetzung - Google Patents
LiposomenzusammensetzungInfo
- Publication number
- ATE223204T1 ATE223204T1 AT93908075T AT93908075T ATE223204T1 AT E223204 T1 ATE223204 T1 AT E223204T1 AT 93908075 T AT93908075 T AT 93908075T AT 93908075 T AT93908075 T AT 93908075T AT E223204 T1 ATE223204 T1 AT E223204T1
- Authority
- AT
- Austria
- Prior art keywords
- liposome composition
- peyer
- glands
- phosphatidylinositol
- cholesterol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/829—Liposomes, e.g. encapsulation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11802592 | 1992-04-10 | ||
| PCT/JP1993/000460 WO1993020801A1 (fr) | 1992-04-10 | 1993-04-09 | Composition de liposomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE223204T1 true ATE223204T1 (de) | 2002-09-15 |
Family
ID=14726206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93908075T ATE223204T1 (de) | 1992-04-10 | 1993-04-09 | Liposomenzusammensetzung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5573779A (de) |
| EP (1) | EP0728476B1 (de) |
| KR (1) | KR100217826B1 (de) |
| AT (1) | ATE223204T1 (de) |
| AU (1) | AU668934B2 (de) |
| CA (1) | CA2117769C (de) |
| DE (1) | DE69332276T2 (de) |
| WO (1) | WO1993020801A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9400600A (pt) * | 1994-02-17 | 1995-10-24 | Finep Financiadora De Estudos | Processos para produção de uma protéina recombinante e/ou de glicosilfosfatidilinositol (GPI) em células de microorganismos eucariontes e para a obtenção de leveduras de S. cerevisae; célula de levedura sequência de nucleotídios; meio de cultura; medicamento ou vacina; e produto dos ditos processos |
| ATE243998T1 (de) | 1995-10-12 | 2003-07-15 | Supergen Inc | Liposomformulierung von 5-beta steroiden |
| US6015576A (en) * | 1997-08-29 | 2000-01-18 | Bio-Sphere Technology, Inc. | Method for inducing a systemic immune response to an antigen |
| US6117449A (en) * | 1996-03-22 | 2000-09-12 | Bio-Sphere Technology, Inc. | Method for inducing a systemic immune response to a hepatitis antigen |
| AU682805B1 (en) * | 1996-03-22 | 1997-10-16 | Biosphere Technologies Inc. | Method for inducing a systemic immune response to an antigen |
| US6207185B1 (en) * | 1996-03-22 | 2001-03-27 | Bio-Sphere Technology | Method for inducing a systemic immune response to an HIV antigen |
| US20020136762A1 (en) * | 1998-01-14 | 2002-09-26 | See Jackie R. | Method for inducing a systemic immune response to an antigen |
| AU4574199A (en) * | 1998-06-16 | 2000-01-05 | Jackie R. See | Method for introducing a chemical agent into the systemic circulation |
| AU2001278336B2 (en) * | 2000-07-31 | 2007-01-18 | Ottawa Heart Institute Research Corporation | Charged phospholipid compositions and methods for their use |
| FR2836043B1 (fr) * | 2002-02-15 | 2004-06-04 | Inst Nat Sante Rech Med | Vesicules lipidiques, preparation et utilisations |
| US7875288B2 (en) * | 2006-03-30 | 2011-01-25 | The Research Foundation Of State University Of New York | Method for treating blood coagulation disorders |
| EP2007357B1 (de) * | 2006-03-30 | 2016-11-09 | The Research Foundation Of State University Of New York | Zusammensetzungen aus weniger immunogenen und langzirkulierenden protein-lipid-komplexen |
| US20090081284A1 (en) * | 2006-04-20 | 2009-03-26 | Tokai University Educational System | Therapeutic agent for allergy containing liposome having oligosaccharide on its surface |
| CN102727437A (zh) * | 2006-08-02 | 2012-10-17 | 牛津大学院长校长专家委员会 | 病毒感染的脂质体治疗 |
| KR20100127842A (ko) * | 2008-03-26 | 2010-12-06 | 유니버시티 오브 옥스퍼드 | 소포체 표적화 리포좀 |
| EP2410989A2 (de) * | 2009-03-27 | 2012-02-01 | The Chancellor, Masters and Scholars of the University of Oxford | Liposome zur senkung des cholesterinspiegels |
| US10617640B2 (en) | 2009-07-07 | 2020-04-14 | The Research Foundation For The State University Of New York | Phosphoserine containing compositions for immune tolerance induction |
| EP2763659B1 (de) * | 2011-10-06 | 2017-07-19 | The Research Foundation Of State University Of New York | Zusammensetzungen und verfahren zur induzierung von immuntoleranz |
| EP2830599B1 (de) | 2012-03-29 | 2018-08-15 | Therabiome, Llc | Ortsspezifische gastrointestinale orale impfrezepte zur wirkung am ileum und am blinddarm |
| US9907755B2 (en) | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| FR3119325B1 (fr) * | 2021-01-29 | 2023-08-11 | Renault Jean Yves | Compositions liposomales orales |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2645444A1 (de) * | 1976-10-08 | 1978-04-13 | Karl Dr Med Theurer | Verfahren zur gewinnung von oral wirksamen arzneimitteln und impfstoffen aus primaer nicht darmwirksamen praeparaten |
| US4837028A (en) * | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US4920016A (en) * | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| US4952405A (en) * | 1988-10-20 | 1990-08-28 | Liposome Technology, Inc. | Method of treating M. avium infection |
| US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
| EP0432693A1 (de) * | 1989-12-11 | 1991-06-19 | Sumitomo Chemical Company, Limited | Für virusinfizierte Zellen cytotoxische Liposomen |
| JPH03236325A (ja) * | 1989-12-11 | 1991-10-22 | Sumitomo Chem Co Ltd | ウイルス感染細胞を殺傷するリポソーム |
| FI944052A0 (fi) * | 1992-03-03 | 1994-09-02 | Daiichi Seiyaku Co | Oraalinen rokote |
-
1993
- 1993-04-09 AU AU39041/93A patent/AU668934B2/en not_active Ceased
- 1993-04-09 US US08/313,231 patent/US5573779A/en not_active Expired - Fee Related
- 1993-04-09 KR KR1019940703508A patent/KR100217826B1/ko not_active Expired - Fee Related
- 1993-04-09 WO PCT/JP1993/000460 patent/WO1993020801A1/ja not_active Ceased
- 1993-04-09 EP EP93908075A patent/EP0728476B1/de not_active Expired - Lifetime
- 1993-04-09 CA CA002117769A patent/CA2117769C/en not_active Expired - Fee Related
- 1993-04-09 DE DE69332276T patent/DE69332276T2/de not_active Expired - Fee Related
- 1993-04-09 AT AT93908075T patent/ATE223204T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69332276T2 (de) | 2003-01-09 |
| EP0728476B1 (de) | 2002-09-04 |
| DE69332276D1 (de) | 2002-10-10 |
| AU668934B2 (en) | 1996-05-23 |
| KR100217826B1 (ko) | 1999-09-01 |
| US5573779A (en) | 1996-11-12 |
| EP0728476A4 (de) | 1997-09-10 |
| AU3904193A (en) | 1993-11-18 |
| CA2117769C (en) | 2003-07-22 |
| KR950700725A (ko) | 1995-02-20 |
| WO1993020801A1 (fr) | 1993-10-28 |
| CA2117769A1 (en) | 1993-10-11 |
| EP0728476A1 (de) | 1996-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950700725A (ko) | 리포솜 조성물(liposome composition) | |
| EP0283713A3 (en) | Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them | |
| ES2130420T3 (es) | Preparado transdermico de sustancia activa. | |
| DE58905028D1 (de) | Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel. | |
| ES8801118A1 (es) | Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado. | |
| FI973828A0 (fi) | Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi | |
| AU3559895A (en) | Polyethylene glycol modified ceramide lipids and liposome uses thereof | |
| ATE65392T1 (de) | In mizellulare phospholipidische partikel eingekapselte antineoplastische anthracyclinmittel. | |
| NO304982B1 (no) | Fosfolipid, fosfatidyletanolamin, farmas°ytisk, nµrings eller kosmetisk blanding omfattende nevnte fosfolipid eller fosfatidyletanolamin | |
| NZ236823A (en) | Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance | |
| DK0871476T3 (da) | Tørret blodfaktorpræparat indeholdende trehalose | |
| DK0699068T3 (da) | Reduktion af liposominducerede fysiologiske bivirkninger | |
| ATE50499T1 (de) | Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. | |
| ES2077904T3 (es) | Obtencion y uso de preparados estables de liposomas en forma de pequeñas particulas. | |
| TR199903192T2 (xx) | Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar. | |
| ES2124328T3 (es) | Liposomas que contienen diacetato de clorhexidina o digluconato de clorhexidina. | |
| PT95697A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas | |
| AU586988B2 (en) | Solid drug formulations and stable suspensions | |
| ZA91115B (en) | Topical compositions | |
| FR2619505B1 (fr) | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la pregnenolone ou un ester de pregnenolone, et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite regeneratrice ou revitalisante, l'incorporant | |
| SG168394G (en) | Method and formulation for orally administering bioactive agents to and through the peyer's patch |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |